ADMA Biologics Inc is on Cruelty Free Investing use of animals list because they test their drugs on animals.
ADMA Biologics obtained U.S. Food and Drug Administration (FDA) approval after the use of animals in their studies. .
ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics.